Scientific Reports (May 2024)

Enhancing diagnostic accuracy of multiple myeloma through ML-driven analysis of hematological slides: new dataset and identification model to support hematologists

  • Caio L. B. Andrade,
  • Marcos V. Ferreira,
  • Brenno M. Alencar,
  • Ariel M. A. Junior,
  • Tiago J. S. Lopes,
  • Allan S. dos Santos,
  • Mariane M. dos Santos,
  • Maria I. C. S. Silva,
  • Izabela M. D. R. P. Rosa,
  • Jorge L. S. B. Filho,
  • Matheus A. Guimaraes,
  • Gilson C. de Carvalho,
  • Herbert H. M. Santos,
  • Márcia M. L. Santos,
  • Roberto Meyer,
  • Tatiane N. Rios,
  • Ricardo A. Rios,
  • Songeli M. Freire

DOI
https://doi.org/10.1038/s41598-024-61420-9
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 11

Abstract

Read online

Abstract Multiple Myeloma (MM) is a hematological malignancy characterized by the clonal proliferation of plasma cells within the bone marrow. Diagnosing MM presents considerable challenges, involving the identification of plasma cells in cytology examinations on hematological slides. At present, this is still a time-consuming manual task and has high labor costs. These challenges have adverse implications, which rely heavily on medical professionals’ expertise and experience. To tackle these challenges, we present an investigation using Artificial Intelligence, specifically a Machine Learning analysis of hematological slides with a Deep Neural Network (DNN), to support specialists during the process of diagnosing MM. In this sense, the contribution of this study is twofold: in addition to the trained model to diagnose MM, we also make available to the community a fully-curated hematological slide dataset with thousands of images of plasma cells. Taken together, the setup we established here is a framework that researchers and hospitals with limited resources can promptly use. Our contributions provide practical results that have been directly applied in the public health system in Brazil. Given the open-source nature of the project, we anticipate it will be used and extended to diagnose other malignancies.